Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT

Digestive Diseases and Sciences

Volumn 56, Issue 10, 2011, Pages 3038-3044

  Shah, Amy G ^a   Smith, Paula G ^a   Sterling, Richard K ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

HIV HCV coinfection; Liver fibrosis; Non invasive markers

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APRI TEST; ARTICLE; COHORT ANALYSIS; FEMALE; FIB 4 TEST; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; THROMBOCYTE COUNT;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; COMORBIDITY; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 80054758405     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1710-2     Document Type: Article

References (46)

1. MS Sulkowski DL Thomas 2003 Hepatitis C in the HIV-infected person Ann Intern Med 138 197 207 12558359 (Pubitemid 36231625)
2. SG Sheth SL Flamm FD Gordon S Chopra 1998 AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection Am J Gastroenterol 93 44 48 9448172 10.1111/j.1572-0241.1998.044-c.x 1:STN:280:DyaK1c7gslylsw%3D%3D (Pubitemid 29065511)
3. FJ Palella Jr KM Delaney AC Moorman HIV Outpatient Study Investigators, et al. 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 853 860 9516219 10.1056/NEJM199803263381301 (Pubitemid 28135961)
4. HK Monga MC Rodriguez-Barradas K Breaux, et al. 2001 Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection Clin Infect Dis 33 240 247 11418885 10.1086/321819 1:STN:280:DC%2BD3MzlslGitw%3D%3D (Pubitemid 32643340)
5. I Bica B McGovern R Dhar, et al. 2001 Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection Clin Infect Dis 32 492 497 11170959 10.1086/318501 1:STN:280: DC%2BD38%2Fgs12kug%3D%3D (Pubitemid 32173638)
6. FJ Torriani M Rodriguez-Torres JK Rockstroh, et al. 2004 Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 438 450 15282351 10.1056/NEJMoa040842 1:CAS:528:DC%2BD2cXmtFalu7k%3D (Pubitemid 38988593)
7. M Laguno J Murillas JL Blanco, et al. 2004 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients AIDS 18 F27 F36 15316335 10.1097/00002030- 200409030-00003 1:CAS:528:DC%2BD2cXmslOnur0%3D
8. RT Chung J Andersen P Volberding, et al. 2004 Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 451 459 15282352 10.1056/NEJMoa032653 1:CAS:528:DC%2BD2cXmtFaktro%3D (Pubitemid 38988594)
9. F Carrat F Bani-Sadr S Pol, et al. 2004 Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2839 2848 15598915 10.1001/jama.292.23.2839 1:CAS:528:DC%2BD2cXhtFWrtbrP (Pubitemid 39628231)
10. AA Bravo SG Sheth S Chopra 2001 Liver biopsy N Engl J Med 344 495 500 11172192 10.1056/NEJM200102153440706 1:STN:280:DC%2BD3M7ksVehtw%3D%3D (Pubitemid 32164902)
11. A Regev M Berho LJ Jeffers, et al. 2002 Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2614 2618 12385448 10.1111/j.1572-0241.2002.06038.x
12. J Perrault DB McGill BJ Ott WF Taylor 1978 Liver biopsy: complications in 1,000 inpatients and outpatients Gastroenterology 74 103 106 618417 1:STN:280:DyaE1c%2FksVajsA%3D%3D (Pubitemid 8248893)
13. DB McGill J Rakela AR Zinsmeister BJ Ott 1990 A 21 year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 99 1396 1400 2101588 1:STN:280:DyaK3M%2FgslSqsA%3D%3D (Pubitemid 20381876)
14. G Colloredo M Guido A Sonzogni G Leandro 2003 Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease J Hepatol 39 239 244 12873821 10.1016/S0168-8278(03) 00191-0 (Pubitemid 36920560)
15. P Bedossa D Dargere V Paradis 2003 Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 1449 1457 14647056 (Pubitemid 37466971)
16. JO Smith RK Sterling 2009 Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C Aliment Pharmacol Ther 30 557 576 19519733 10.1111/j.1365-2036.2009.04062.x 1:STN:280:DC%2BD1MrnsVKrsw%3D%3D
17. A Pohl C Behling D Oliver M Kilani P Monson T Hassanein 2001 Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection Am J Gastroenterol 96 3142 3146 11721762 10.1111/j.1572-0241.2001.05268.x 1:CAS:528:DC%2BD3MXpt1Kmtbw%3D (Pubitemid 33095354)
18. DM Bissell 2004 Assessing fibrosis without a liver biopsy: are we there yet? Gastroenterology 127 1847 1849 15578524 10.1053/j.gastro.2004.10.012 (Pubitemid 39575865)
19. E Rossi L Adams A Prins, et al. 2003 Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients Clin Chem 49 450 454 12600957 10.1373/49.3.450 1:CAS:528:DC%2BD3sXhvFSksb8%3D (Pubitemid 36250205)
20. WM Rosenberg M Voelker R Thiel, et al. 2004 Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 1704 1713 15578508 10.1053/j.gastro.2004.08.052 (Pubitemid 39575849)
21. T Poynard J McHutchison M Manns RP Myers J Albrecht 2003 Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 481 492 12883493 10.1053/jhep.2003.50319 1:CAS:528:DC%2BD3sXmvFSmurs%3D (Pubitemid 36919870)
22. K Patel SC Gordon I Jacobson, et al. 2004 Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients J Hepatol 41 935 942 15582126 10.1016/j.jhep.2004.08.008 1:CAS:528:DC%2BD2cXhtVCgsLzK (Pubitemid 39575660)
23. F Imbert-Bismut V Ratziu L Pieroni F Charlotte Y Benhamou T Poynard 2001 Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 1069 1075 11297957 10.1016/S0140-6736(00)04258-6 1:CAS:528:DC%2BD3MXislGns70%3D (Pubitemid 32322537)
24. CT Wai JK Greenson RJ Fontana, et al. 2003 A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 518 526 12883497 10.1053/jhep.2003.50346 (Pubitemid 36919874)
25. Thabut D, Simon M, Myers RP, et al. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology. 2003;37:1220-1221; author reply 1.
26. A Sud JM Hui GC Farrell, et al. 2004 Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index Hepatology 39 1239 1247 15122752 10.1002/hep.20207 (Pubitemid 38569045)
27. Patel K, Muir AJ, McHutchison JG. Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients. Hepatology. 2003;37:1222; author reply -3.
28. C Lackner G Struber B Liegl, et al. 2005 Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C Hepatology 41 1376 1382 15915455 10.1002/hep.20717 (Pubitemid 40770291)
29. X Forns S Ampurdanes JM Llovet, et al. 2002 Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 986 992 12297848
30. RK Sterling MJ Contos AJ Sanyal, et al. 2003 The clinical spectrum of hepatitis C virus in HIV coinfection J Acquir Immune Defic Syndr 32 30 37 12514411 10.1097/00126334-200301010-00005 1:CAS:528:DC%2BD3sXmsFyl (Pubitemid 36091482)
31. ML Shiffman CA Stewart CM Hofmann, et al. 2000 Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy J Infect Dis 182 1595 1601 11069229 10.1086/317612 1:STN:280:DC%2BD3M%2FnvF2mug%3D%3D
32. M Martinot-Peignoux N Boyer D Cazals-Hatem, et al. 2001 Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA Hepatology 34 1000 1005 11679971 10.1053/jhep.2001.28458 1:STN:280: DC%2BD3MrntF2ktA%3D%3D (Pubitemid 33032035)
33. SA Gonzalez RC Liu BR Edlin IM Jacobson AH Talal 2006 HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels J Acquir Immune Defic Syndr 41 582 589 16652026 10.1097/01.qai.0000214806.90841.c8 1:CAS:528:DC%2BD28XktVWhurY%3D
34. RK Sterling E Lissen N Clumeck, et al. 2006 Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 1317 1325 16729309 10.1002/hep.21178 1:CAS:528:DC%2BD28XmsF2nur0%3D (Pubitemid 43980111)
35. RK Sterling J Wegelin P Smith, et al. 2010 Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: analysis of paired liver biopsy samples Clin Gastroenterol Hepatol 12 1070 1076 10.1016/j.cgh.2010.08.004
36. Y Benhamou V Di Martino M Bochet, et al. 2001 Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy Hepatology 34 283 287 11481613 10.1053/jhep.2001.26517 1:CAS:528:DC%2BD3MXmtVGqt7o%3D (Pubitemid 32702341)
37. L Martin-Carbonero Y Benhamou M Puoti, et al. 2004 Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study Clin Infect Dis 38 128 133 14679458 10.1086/380130 (Pubitemid 38045883)
38. RK Sterling MS Wilson AJ Sanyal, et al. 2004 Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfection Clin Gastroenterol Hepatol 2 432 439 15118983 10.1016/S1542-3565(04)00129-6 1:CAS:528:DC%2BD2cXkvFGrsL0%3D (Pubitemid 38561242)
39. S Pol 2001 Hepatitis C virus and human immunodeficiency virus co-infection Gastroenterol Clin Biol 25 B152 B156 11449156 1:STN:280: DC%2BD3MvjvFGrtg%3D%3D
40. K Langohr A Sanvisens D Fuster, et al. 2008 Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patients Open AIDS J 2 82 88 19274066 10.2174/1874613600802010082 1:CAS:528:DC%2BD1MXmsFOl
41. L Fonquernie L Serfaty A Charrois, et al. 2004 Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients HIV Med 5 385 390 15369515 10.1111/j.1468-1293.2004. 00239.x 1:STN:280:DC%2BD2cvoslSmtg%3D%3D (Pubitemid 39276338)
42. C Uberti-Foppa A De Bona L Galli, et al. 2006 Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels J Acquir Immune Defic Syndr 41 63 67 16340475 10.1097/01.qai.0000192001.15777.15 1:CAS:528:DC%2BD2MXht1yitbzM (Pubitemid 41786021)
43. H Al-Mohri T Murphy Y Lu RG Lalonde MB Klein 2007 Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker J Acquir Immune Defic Syndr 44 463 469 17211282 10.1097/QAI.0b013e318030ff8e (Pubitemid 46555383)
44. M Persico E Persico R Suozzo, et al. 2000 Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels Gastroenterology 118 760 764 10734027 10.1016/S0016-5085(00)70145-4 1:STN:280: DC%2BD3c3gtVegsA%3D%3D (Pubitemid 30171625)
45. D Prati E Taioli A Zanella, et al. 2002 Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 1 10 12093239 1:CAS:528:DC%2BD38Xls1entbc%3D
46. AJ Sanyal RJ Fontana AM Di Bisceglie, et al. 2006 The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis Gastrointest Endosc 64 855 864 17140886 10.1016/j.gie.2006.03. 007 (Pubitemid 44829826)